Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicky Welton

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Health Economics|November 5, 2011
Research decisions in the face of heterogeneity: what can a new study tell us?Nicky Welton, A E Ades
Pharmacoeconomics|June 28, 2017
Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness ModellingHoward Thom, Chris Jackson, Nicky Welton, et al.
Pharmacoeconomics|March 26, 2017
Using Parameter Constraints to Choose State Structures in Cost-Effectiveness ModellingHoward Thom, Chris Jackson, Nicky Welton, et al.
Pharmaceutical Statistics|December 6, 2016
Α Markov model for longitudinal studies with incomplete dichotomous outcomesOrestis Efthimiou, Nicky Welton, Myrto Samara, et al.
Plos One|June 2, 2015
Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practiceSarah Donegan, Lisa Williams, Sofia Dias, et al.
Addiction (Abingdon, England)|April 23, 2013
Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflictMatthew Hickman, Daniela De Angelis, Hayley Jones, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 29, 2015
Diagnostic value of symptoms of oesophagogastric cancers in primary care: a systematic review and meta-analysisMargaret P Astin, Tanimola Martins, Nicky Welton, et al.
Pharmacoeconomics|February 1, 2006
Bayesian methods for evidence synthesis in cost-effectiveness analysisA E Ades, Mark Sculpher, Alex Sutton, et al.
Annals of Family Medicine|March 27, 2023
Assessing Representativeness of Randomised Controlled Trials using Serious Adverse EventsPeter Hanlon, David McAllister, Sarah Wild, et al.
Health Technology Assessment (Winchester, England)|June 17, 2016
A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adultsPetros Skapinakis, Deborah Caldwell, William Hollingworth, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Health Economics|November 5, 2011
Research decisions in the face of heterogeneity: what can a new study tell us?Nicky Welton, A E Ades
Pharmacoeconomics|June 28, 2017
Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness ModellingHoward Thom, Chris Jackson, Nicky Welton, et al.
Pharmacoeconomics|March 26, 2017
Using Parameter Constraints to Choose State Structures in Cost-Effectiveness ModellingHoward Thom, Chris Jackson, Nicky Welton, et al.
Pharmaceutical Statistics|December 6, 2016
Α Markov model for longitudinal studies with incomplete dichotomous outcomesOrestis Efthimiou, Nicky Welton, Myrto Samara, et al.
Plos One|June 2, 2015
Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practiceSarah Donegan, Lisa Williams, Sofia Dias, et al.
Addiction (Abingdon, England)|April 23, 2013
Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflictMatthew Hickman, Daniela De Angelis, Hayley Jones, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 29, 2015
Diagnostic value of symptoms of oesophagogastric cancers in primary care: a systematic review and meta-analysisMargaret P Astin, Tanimola Martins, Nicky Welton, et al.
Pharmacoeconomics|February 1, 2006
Bayesian methods for evidence synthesis in cost-effectiveness analysisA E Ades, Mark Sculpher, Alex Sutton, et al.
Annals of Family Medicine|March 27, 2023
Assessing Representativeness of Randomised Controlled Trials using Serious Adverse EventsPeter Hanlon, David McAllister, Sarah Wild, et al.
Health Technology Assessment (Winchester, England)|June 17, 2016
A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adultsPetros Skapinakis, Deborah Caldwell, William Hollingworth, et al.
Pageof 2